M Ventures is the strategic corporate venture capital fund of Merck KGaA, Darmstadt, Germany. Established in 2009, it manages a fund of €600 million, investing in biotechnology and technology sectors. The fund focuses on healthcare drug development, life science tools, electronics, and frontier technology and sustainability. M Ventures aims to support visionary companies that develop innovative solutions for treating diseases, advancing scientific research, and addressing sustainability challenges. They take an active role in their portfolio companies, collaborating closely with entrepreneurs and co-investors.